Select Medical Holdings Corp

This non-binding say-on-pay proposal asks shareholders to approve the Company’s executive compensation program as disclosed in the proxy, including the Compensation Discussion and Analysis, compensation tables and narrative. Management seeks this advisory endorsement to validate its approach of tying a significant portion of NEO pay to pre-determined financial metrics (primarily earnings per share and return on equity), to reinforce the alignment between management incentives and stockholder returns, and to support retention through multi-year equity awards. The Compensation Committee sets bonus targets and a detailed performance matrix linking EPS and ROE to bonus payout percentages and granted time-based restricted stock awards to promote long-term alignment given regulatory and Medicare-driven revenue variability. The Board points to prior strong shareholder support (approximately 91% in 2025) as evidence the program has stockholder acceptance, and it intends to consider the advisory vote results in future compensation design decisions. The vote is advisory and non-binding, but management frames it as an important feedback mechanism; a favorable vote supports continuation of current pay structures while a negative vote would trigger further engagement and potential program adjustments. Key governance context includes compensation recoupment policies, stock ownership guidelines for executives, and the Compensation Committee’s oversight and discretion over final award determinations. Investors should evaluate the program’s mix of short- and long-term incentives, the defensiveness of time-based versus performance-based equity in a Medicare-dependent business, and whether the pay-for-performance linkage through EPS and ROE targets adequately captures long-term value creation. The Board’s recommendation emphasizes alignment with stockholder interests and retention needs, while acknowledging the advisory nature of the vote and the Committee’s openness to stockholder input.

This management proposal would amend the Company’s Certificate of Incorporation to phase out the Board’s classified (staggered) structure over a defined transition beginning with the 2026 and 2027 elections so that, by the 2028 annual meeting, all directors would be elected annually to one-year terms. Management is seeking shareholder approval to increase director accountability and enable shareholders to express views on Board composition and performance annually, responding to prior stockholder feedback and broader market governance trends. The Board considered the traditional arguments for a classified board (continuity, stability, defense against opportunistic takeovers) and weighed them against the stockholder demands for annual elections and increased accountability. The Board concluded that declassification better aligns with stockholder preferences and deems the change advisable, while also implementing procedural language to phase in the change without shortening the remaining terms of current directors. The voting standard for approval is a majority of outstanding shares; this is a substantive charter amendment and therefore requires affirmative support from a majority of all outstanding shares. If approved, directors elected at the 2026 meeting would serve one-year terms, with complete annual elections effective in 2028. For investors, this change reduces the insulating effects of staggered terms and increases the potential for more rapid board turnover in response to performance or governance concerns, while still allowing the Board to manage transitions in a phased manner. The Board recommends FOR approval but acknowledges the trade-offs between long-term continuity and direct annual accountability, and the proposal should be assessed in the context of the Company’s engagement with institutional holders and recent shareholder feedback urging declassification.

Proposal 5 is a management-sponsored, non-binding advisory request asking stockholders to support an amendment to the bylaws providing that stockholders holding at least 25% of outstanding common stock continuously for one year (and meeting procedural requirements) may call a special meeting. Management frames the higher 25% threshold and one-year holding period as a compromise that expands shareholder rights while limiting the risk that a small or transient holder could force an expensive, distracting special meeting for narrow or self-interested reasons. The Board emphasizes administrative and operational costs, the time management and employees must devote to special meetings, and the risk of a nominal number of holders (given the ownership distribution) being able to convene a meeting at lower thresholds. The proposal is advisory, so even if approved the Board will weigh the result alongside ongoing engagement before implementing any bylaw changes. In recommending FOR, the Board cites market practice among many S&P 500 companies and argues the 25% level better balances responsiveness to stockholders with protection of long-term corporate strategy than the competing 10% stockholder proposal. From a governance perspective, a 25% threshold concentrates calling power in a materially large and likely institutional group, reducing the potential for tactical activism, but it also raises the bar for shareholder-initiated corrective action and may delay swift redress of urgent issues that lack 25% sponsor support. Investors should evaluate whether the 25% threshold unduly insulates management relative to peer norms and consider the company’s shareholder composition (several large institutional holders). The vote will be an important signal of stockholders’ appetite for broader special meeting rights versus the Board’s desire to limit opportunistic or fragmented calls for meetings.

This shareholder proposal, submitted by John Chevedden, requests a bylaw amendment granting holders of a combined 10% of outstanding shares the power to call a special meeting (or the lowest state-law threshold), with no holding-period restrictions and allowing online meetings. The proponent argues such a right acts as a governance backstop against board complacency, facilitates timely shareholder engagement, and is feasible given online meeting technology, citing examples where similar proposals obtained majority support at other companies. Management counters that a 10% threshold would enable one large holder or a small coalition (noting the company’s three largest holders are ~14.1%, ~12.9% and ~10.5%) to unilaterally call special meetings, imposing significant operational cost and distracting management, and could enable pursuit of narrow agendas not shared broadly by holders. The Board prefers its own advisory Proposal 5 establishing a 25%/one-year threshold as a compromise to broaden rights while reducing susceptibility to tactical activism. The company-specific context includes the ownership concentration among large institutions, the administrative expense of special meetings, and recent stockholder outreach that produced management’s 25% proposal. Investors evaluating this proposal should weigh the trade-off between easier access to extraordinary corporate action that can correct governance failures quickly versus the increased risk of opportunistic or repeated special meetings called by relatively small but sizeable holders; they should also consider the non-binding nature of the proposal and how management’s response (Proposal 5) might be implemented if supported.